FindTrial
Sign In

Questionnaire Survey of Asthma patients in 4 Indian cities

Asthma Control Survey 2012(Community based patient questionnaire survey to assess Asthma Control in 4 Indian cities) - OTH116516

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/12/003256
Enrollment
550
Registered
2012-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Asthma

Interventions

None listed

Sponsors

Glaxo Smith Kline Pharmaceuticals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Physician diagnosed Asthma together with either current use of Asthma medication or the occurence of Asthm attacks and symptoms during the previous year.

Exclusion criteria

Exclusion criteria: Individuals with smoking Index more than 100 will be excluded from this survey

Design outcomes

Primary

MeasureTime frame
1. Proportion of all patients with â??not well controlledâ?? asthma (ACT score less than or equal to 19). 2. Proportion of all patients with â??controlledâ?? asthma (ACT score more than 19). Timepoint: 3 months—

Secondary

MeasureTime frame
Current level of asthma control based upon ACT score (stratified by age), usage of diagnostic and monitoring tools for asthma, usage of different classes of asthma medication, level of healthcare utilization, level of work productivity and activity impairment (WPAI), relation between ACT score and WPAI outcomes, between ACT score and different classes of asthma medication, between ACT score and adherence to asthma medication.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr Sadhna Joglekar

Glaxosmith Kline Pharmaceuticals

sadhna.j.joglekar@gsk.com02224959405

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026